| Bone metastases in non-small cell lung cancer: A narrative review BJ Knapp, S Devarakonda, R Govindan Journal of Thoracic Disease 14 (5), 1696, 2022 | 19 | 2022 |
| Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine MM Im, SA Flanagan, JJ Ackroyd, B Knapp, A Kramer, DS Shewach Radiation research 186 (5), 466-477, 2016 | 8 | 2016 |
| Posttreatment DSC-MRI is Predictive of Early Treatment Failure in Children with Supratentorial High-Grade Glioma Treated with Erlotinib JT Lucas Jr, BJ Knapp, J Uh, CH Hua, TE Merchant, SN Hwang, Z Patay, ... Clinical neuroradiology 28 (3), 393-400, 2018 | 6 | 2018 |
| Exploring the feasibility of utilizing limited gene panel circulating tumor DNA clearance as a biomarker in patients with locally advanced non-small cell lung cancer B Knapp, L Mezquita, S Devarakonda, M Aldea, SN Waqar, K Pepin, ... Frontiers in Oncology 12, 856132, 2022 | 4 | 2022 |
| The changing landscape of small cell lung cancer GF Cittolin‐Santos, B Knapp, B Ganesh, F Gao, S Waqar, ... Cancer, 2024 | 1 | 2024 |
| Outcomes in Patients with Spinal Metastases Managed with Surgical Intervention B Knapp, A Govindan, SS Patel, K Pepin, N Wu, S Devarakonda, ... Cancers 16 (2), 438, 2024 | 1 | 2024 |
| Prognostic impact of clinical stage on non-surgical patients with pleural mesothelioma. B Knapp, GF Cittolin Santos, N Wu, ME Flanagan, M Baral, F Gao, ... Journal of Clinical Oncology 42 (16_suppl), e20096-e20096, 2024 | | 2024 |
| Temporal trends in clinical and pathologic stage discordance in resectable non-small cell lung cancer. GF Cittolin Santos, B Knapp, ME Flanagan, S Tohmasi, BD Kozower, ... Journal of Clinical Oncology 42 (16_suppl), e20068-e20068, 2024 | | 2024 |
| Incidence and risk factors for bone metastases at presentation in solid tumors BJ Knapp, GF Cittolin-Santos, ME Flanagan, N Grandhi, F Gao, ... Frontiers in Oncology 14, 2024 | | 2024 |
| The incidence and risk factors predictive of bone metastases at initial diagnosis of malignancy. B Knapp, ME Flanagan, N Grandhi, B Ganesh, GF Cittolin Santos, F Gao, ... Journal of Clinical Oncology 41 (16_suppl), e18816-e18816, 2023 | | 2023 |
| FP07. 11 Circulating Tumor DNA (ctDNA) Clearance as a Biomarker in Patients With Locally Advanced NSCLC Following Chemoradiation B Knapp, L Mezquita, S Devarakonda, M Aldea, S Waqar, K Pepin, ... Journal of Thoracic Oncology 16 (3), S208, 2021 | | 2021 |
Ramaswamy GovindanVerified email at im.wustl.edu
